ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Translational Potential of Fluorescent PARP1 Inhibitor as a Molecular Contrast Agent for Diagnosis of Basal Cell Carcinoma.

Miriam Ricanati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.